» Authors » George M Abraham

George M Abraham

Explore the profile of George M Abraham including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 349
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gogtay M, Yadukumar L, Singh Y, Suresh M, Soni A, Yekula A, et al.
World J Virol . 2024 Sep; 13(3):92647. PMID: 39323450
Background: Chronic hepatitis C virus (HCV) has been associated with hepatic and extrahepatic malignancies. Limited studies have shown an association between colorectal adenomas and HCV populations. Aim: To study the...
2.
Shanmugavel Geetha H, Teo Y, Ravichandran S, Perkit N, Gogtay M, Lal A, et al.
Respir Med . 2024 Sep; 234:107819. PMID: 39321996
Background: The Sodium-Glucose Cotransporter 2 inhibitors (SGLT2i) are a class of anti-diabetic medications that confer cardio-renal-metabolic (CRM) benefits. Emerging evidence also suggests that these agents provide better benefits for chronic...
3.
Qaseem A, Yost J, Abraham G, Andrews R, Jokela J, Miller M, et al.
Ann Intern Med . 2024 Jul; 177(8):e2400128. PMID: 38976885
No abstract available.
4.
Shanmugavel Geetha H, Prabhu S, Sekar A, Gogtay M, Singh Y, Mishra A, et al.
World J Virol . 2024 Jan; 12(5):286-295. PMID: 38187498
Background: Studies have shown elevated C-reactive protein (CRP) to predict mechanical ventilation (MV) in patients with coronavirus disease 2019 (COVID-19). Its utility is unknown in patients with chronic kidney disease...
5.
Suresh M, Gogtay M, Singh Y, Yadukumar L, Mishra A, Abraham G
World J Clin Cases . 2023 Dec; 11(34):8126-8138. PMID: 38130793
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Studies have shown a strong association between non-alcoholic steatohepatitis (NASH) cirrhosis and portal vein...
6.
Qaseem A, Yost J, Abraham G, Andrews R, Jokela J, Miller M, et al.
Ann Intern Med . 2023 Sep; 176(10):1396-1404. PMID: 37722112
Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP)...
7.
Shanmugavel Geetha H, Singh G, Sekar A, Gogtay M, Singh Y, Abraham G, et al.
World J Clin Cases . 2023 Mar; 11(6):1287-1298. PMID: 36926123
Background: New onset hyperglycemia is common in patients with severe coronavirus disease 2019 (COVID-19) infection. Cytokine storm due to COVID-19 infection is an essential etiology for new-onset hyperglycemia, but factors...
8.
Saha A, Balakrishnan S, Trivedi N, Abraham G
AACE Clin Case Rep . 2023 Jan; 9(1):2-4. PMID: 36654996
Background: Topical use of corticosteroids causes systemic effects, but systemic toxicity by ingesting topical corticosteroid cream has not been reported. We describe a patient admitted with ingestion of over-the-counter (OTC)...
9.
Qaseem A, Yost J, Miller M, Andrews R, Jokela J, Forciea M, et al.
Ann Intern Med . 2022 Nov; 176(1):115-124. PMID: 36442061
Description: Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data emerge on SARS-CoV-2 variants and the availability of newer treatments. The Scientific Medical Policy Committee...
10.
Singh Y, Gogtay M, Gurung S, Trivedi N, Abraham G
J Community Hosp Intern Med Perspect . 2022 Nov; 12(4):58-65. PMID: 36348970
This retrospective, cross-sectional study aimed to evaluate the predictive factors of moderate/severe hepatic steatosis diagnosed by vibration-controlled transient elastography (VCTE). It included 158 adult patients with suspected nonalcoholic fatty liver...